This episode of "The Brain Health Revolution" features John Robbins, son of the Baskin-Robbins founder. He famously chose to forgo immense wealth, instead pursuing a "deeper American Dream"

This episode of "The Brain Health Revolution" features John Robbins, son of the Baskin-Robbins founder. He famously chose to forgo immense wealth, instead pursuing a "deeper American Dream" focused on a society at peace with its conscience, living in harmony with all life, and practicing compassionate ecosystem stewardship.

A powerful advocate for a sane, ethical, and sustainable future, Robbins has spoken at major conferences, received prestigious honors like the Rachel Carson Award, and appeared on national shows. He co-founded and presides over the Food Revolution Network, which empowers over 600,000 members to transform food systems for healthy people and a healthy planet.

On April 28, 2012, the Seventh National Clinical Conference on Cannabis Therapeutics, hosted by Patients Out of Time, featured Andrew Weil, MD. Dr. Weil, founder and director of the Arizona Center

On April 28, 2012, the Seventh National Clinical Conference on Cannabis Therapeutics, hosted by Patients Out of Time, featured Andrew Weil, MD. Dr. Weil, founder and director of the Arizona Center for Integrative Medicine at the University of Arizona, discussed the challenges and future of natural cannabis and cannabinoids in modern medicine.

His presentation highlighted therapeutic benefits such as cannabis's opioid-sparing effect, spasticity relief, and neurological advantages for conditions like MS and ALS. He also addressed its role in modulation and improving quality of life. Following his talk, panel moderator Clint Werner questioned Dr. Weil about his early research into cannabis.

In April 2008, the Fifth National Clinical Conference on Cannabis Therapeutics in Pacific Grove, CA, highlighted research by Dr. Arno Hazecamp. Commissioned by the Dutch government's Office of

In April 2008, the Fifth National Clinical Conference on Cannabis Therapeutics in Pacific Grove, CA, highlighted research by Dr. Arno Hazecamp. Commissioned by the Dutch government's Office of Medicinal Cannabis, his study on cannabis tea revealed relatively high concentrations of THCA (THC Acid) rather than decarboxylated THC.

The conference was sponsored by the University of California's School of Medicine and Patients Out of Time. This information was published on May 5, 2013.

Donald Abrams, M.D., Chief of Hematology and Oncology at San Francisco General Hospital, co-authored *Integrative

Donald Abrams, M.D., Chief of Hematology and Oncology at San Francisco General Hospital, co-authored *Integrative Oncology*. A pioneer in medical cannabis research, he has extensive experience with cancer and HIV/AIDS patients.

The U.S. government classifies cannabis as a Schedule I drug—the most restricted category—asserting it is unsafe with no accepted medical use.

Despite this, medical cannabis has been used for millennia, with no reported overdoses. Moreover, recent global clinical research consistently demonstrates its medicinal value.